SREBF1 and neoplasm: It has been shown that in tumor-bearing K14-Cre; Brca1f/f; p53f/f mice that represent BRCA1-associated TNBC, SREBP1 contributes to the PARP inhibitor resistance and that the inhibition of SREBP1 can reverse the metabolic state of macrophages and the resistance [88].